DDX3X and breast carcinoma: Here, we show that FHP01 exerts very effective antiproliferative and killing activity against different breast cancer cell types and strongly inhibits tumor growth in xenograft models, supporting the hypothesis that targeted inhibition of DDX3X helicase activity is potentially exploitable in breast cancer patients and may positively affect the prognosis of this disease.